| Authors: |
DuBois SG; From Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts (DuBois, Crompton, Janeway)., Krailo MD; Children's Oncology Group Statistics and Data Center, Monrovia, California (Krailo, Buxton)., Buxton A; Children's Oncology Group Statistics and Data Center, Monrovia, California (Krailo, Buxton)., Lessnick SL; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute, Nationwide Children's Hospital, and the Division of Pediatric Heme/Onc/BMT, the Ohio State University College of Medicine, Columbus (Lessnick)., Teot LA; The Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts (Teot)., Rakheja D; The Department of Pathology, University of Texas Southwestern Medical Center, Dallas (Rakheja)., Crompton BD; From Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts (DuBois, Crompton, Janeway)., Janeway KA; From Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts (DuBois, Crompton, Janeway)., Gorlick RG; The Department of Pediatrics, MD Anderson Cancer Center, Houston, Texas (Gorlick)., Glade-Bender J; The Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York (Glade-Bender). |
